Press release
Gene and Cell Therapies Targeting CNS Disorders Market Poised for Substantial Growth Driven by Partnerships Pipeline Innovation and Regulatory Backing
Gene and Cell Therapies Targeting CNS Disorders Market
According to the latest research by Insight Analytics, the global Gene and Cell Therapies Targeting CNS Disorders market is expected to reach a CAGR of 30.5 % during a forecast period of 2025-2034.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1258
Central nervous system (CNS) disorders encompass a broad spectrum of conditions that impair cognitive and motor functions, significantly affecting individuals' ability to perform daily activities. These disorders may arise from infectious diseases, genetic mutations, physical trauma, or a combination thereof. In recent years, the application of cell-based therapies for CNS disorders has advanced beyond preliminary clinical research. Numerous clinical trials are currently investigating the efficacy of cell therapy for conditions such as stroke, traumatic brain injury, Parkinson's disease, and other neurological disorders. Implanted cells have demonstrated the potential to function autonomously within the host tissue, secreting a range of trophic factors that offer neuroprotective and neurorestorative benefits.
Gene transfer technologies are playing a pivotal role in enhancing therapeutic outcomes, offering potential genetic protection against neurodegenerative diseases. The increasing global prevalence of CNS disorders is a major factor driving the growth of gene and cell therapies in this field. Market expansion is further supported by favorable government initiatives, growing ethical acceptance, and rising healthcare expenditures. Additionally, the presence of robust healthcare infrastructure and reimbursement frameworks are encouraging the adoption of these advanced therapies.
Strategic collaborations among key industry players, including licensing and equity agreements, are expected to propel market growth over the forecast period. Continued innovation in gene-editing technologies aimed at repairing neurological damage is also anticipated to accelerate market expansion. However, the high costs associated with gene and cell therapies may pose a significant barrier to widespread adoption in the short to medium term.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-01
Geographically, North America is projected to lead the market due to the increasing number of product launches and regulatory approvals. Moreover, collaborative efforts among major market participants to develop gene-modifying treatments will likely stimulate further growth. Europe is also expected to experience substantial growth, supported by its longstanding integration of biotechnology in healthcare and continued investment in research and development. Overall, strategic partnerships and advancements in therapeutic technologies are poised to drive the global market for gene and cell therapies targeting CNS disorders.
Major market players operating in the gene and cell therapies targeting CNS disorders market include
Novartis, Brainstorm Cell Therapeutics, Helminth, Core set, Q therapeutics, Helminth, Rapa Therapeutics, Brainstorm Cell Therapeutics, Neuroblast, Osteocyte Orchard Therapeutics plc. (UK), SIBIONO (China), Shanghai Sunway Biotech Co., Ltd. (China), bluebird bio, Inc. (US), Human Stem Cells Institute (Russia), Ange's, Inc. (Japan), Alnylam Pharmaceuticals, Inc. (US), Sarepta Therapeutics (US), Jazz Pharmaceuticals, Inc. (Ireland), Ackee Therapeutics (US), and Donavan Technologies (US).
Recent collaborations and agreements in the market:
• In June 2021, CRISPR Therapeutics agreed to a partnership with privately held company Capsida Biotherapeutics to work together on ALS and nerve illness medicines. To more easily focus on the tissues of the focal nervous system, the partners must apply Capsida's innovation. For the two projects, CRISPR will create the tools that modify genes, and Capsida will create the viral protein shells that carry the drugs.
• In August 2020, ABO-202 was an adeno-associated virus (AAV) gene therapy for CLN1 illness. Abeona Therapeutics Inc. and Taysha Gene Therapies announced that they entered into license and equity purchase agreements for it (also known as juvenile Batten disease).
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1258
Market Segments
Global Gene and Cell Therapies Targeting CNS Disorders Market, by Products, 2022-2030 (Value US$ Mn)
• Gene Therapy
• Cell Therapy
Global Gene and Cell Therapies Targeting CNS Disorders Market, by Indication, 2022-2030 (Value US$ Mn)
• Amyotrophic Lateral Sclerosis
• Multiple sclerosis
• Spinal Cord Injury
• Alzheimer
• Parkinson Disease
• Huntington
• Other Indications
Global Gene and Cell Therapies Targeting CNS Disorders Market, by region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Gene and Cell Therapies Targeting CNS Disorders Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Gene and Cell Therapies Targeting CNS Disorders Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Gene and Cell Therapies Targeting CNS Disorders Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Gene and Cell Therapies Targeting CNS Disorders Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Gene and Cell Therapies Targeting CNS Disorders Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
o Rest of Middle East & Africa
Why should buy this report:
To receive a comprehensive analysis of the prospects for the global gene and cell therapies targeting CNS disorders market
To receive an industry overview and future trends in the gene and cell therapies targeting CNS disorders market
To analyze the gene and cell therapies targeting CNS disorders market drivers, and challenges
To get information on the gene and cell therapies targeting CNS disorders market value (US$Mn) forecast to 2030
Significant investments, mergers & acquisitions in the gene and cell therapies targeting CNS disorders market industry
Read Overview Report- https://www.insightaceanalytic.com/report/global-gene-and-cell-therapies-targeting-cns-disorders-market/1258
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gene and Cell Therapies Targeting CNS Disorders Market Poised for Substantial Growth Driven by Partnerships Pipeline Innovation and Regulatory Backing here
News-ID: 4126014 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Biomanufacturing Viral Detection and Quantification Market Report on the Untappe …
InsightAce Analytic Pvt. Ltd. announces the release of the market assessment report on "Global Biomanufacturing Viral Detection and Quantification Market Size, Share & Trends Analysis Report By Offering Type (Consumables, Instruments, Services), By Technology (PCR, ELISA, Flow Cytometry, Plaque Assay, and Others), By Application (Blood and Blood Products Manufacturing, Vaccines and Therapeutics Manufacturing, Cellular and Gene Therapy Products Manufacturing, Stem Cell Products Manufacturing, Tissue and Tissue Products Manufacturing), By…
Minichromosomal Technology in Agriculture Market Know the Scope and Trends
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Minichromosomal Technology in Agriculture Market- (By Trait Incorporated (Drought Tolerance, Improved Nitrogen Use, Herbicide Tolerance, Pest Resistance, Others), By Crop Type (Arabidopsis, Maize, Others), By End-user (Agriculture & Biotechnology Companies, Academic & Research Institutes, Others)) Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Minichromosomal Technology…
Mesophase Pitch-Based Carbon Fiber Market Exclusive Report with Detailed Study A …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Mesophase Pitch-Based Carbon Fiber Market - (By Type (High Modulus Type, Low Modulus Type), By Application (Aerospace and Defense, Automotive, Wind Energy, Sporting Goods, Construction and Infrastructure, Electrical and Electronics)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Mesophase Pitch-Based Carbon Fiber Market is valued…
Medical Polytetrafluoroethylene (PTFE) Market Exclusive Report on the Latest Rev …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Medical Polytetrafluoroethylene (PTFE) Market- (By Product (Sheets, Tubes, Films, Gaskets And Seals, Rods, Powder), By Application (Medical device components, Catheters, Surgical Instruments, Implants, Diagnostic Equipment, Drug Delivery Systems, Lab Equipment, Coatings And Linings, Others), By End Users (Hospitals, Clinics and Ambulatory Surgical Centers (ASCs), Medical Device Manufacturers, Pharmaceutical Companies, Research and Academic Institutes)), Trends, Industry…
More Releases for CNS
CNS promotes craftsmanship of towel production in China
[https://youtu.be/oP-N73N0ey0]
China News Service (CNS) issued a press release and a promo video here on Wednesday to promote the unique craftsmanship of towel production in Gaoyang [https://youtu.be/oP-N73N0ey0] County of Chinese northern Hebei Province.
According to the CNS press release, Gaoyang is the largest hub of towel production in China, where one out of every three towels in the nation originates. More than 4200 textile enterprises are competing to flourish in this region,…
Gene Therapy in CNS Disorder Market - Unlocking the Potential of Gene Therapy: T …
Newark, New Castle, USA: The "Gene Therapy in CNS Disorder Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Gene Therapy in CNS Disorder Market: https://www.growthplusreports.com/report/gene-therapy-in-cns-disorder-market/8886
This latest report…
Central Nervous System (CNS) Therapeutic Market Central Nervous System (CNS) The …
MARKET INTRODUCTION
The central nervous system (CNS) is the control panel of the body, which is responsible for cognition, movement, senses and emotions. Central nervous system diseases, is a group of neurological disorders that affect the structure or function of the brain or spinal cord, which collectively form the central nervous system (CNS). The CNS diseases include neurodegenerative diseases, neurodevelopmental diseases and traumatic injuries. Drugs such as analgesics, anesthetics, nervous system…
Neuro Critical Care Market Insights in terms of volume and value 2018 to 2028(Mo …
Neuro critical care is an emerging field that combines the specialties that link neurology, neurosurgery, and critical care. Just as the field has evolved from primary focus on post-operative care to elective neurosurgical patients, the focus towards the resuscitation of neurological emergency cases such as traumatic brain injury or subarachnoid hemorrhage, which remain a clinical challenge. The neuro critical care market is strongly driven by the increasing focus, awareness, and…
US CNS Disorders Drug Pipeline Insight 2014
The Central Nervous System (CNS) disorders market in US is one of the largest segments of pharmaceuticals industry. In US, the numbers of CNS disorders have increased at an alarming rate, while the available therapies were unable to meet the market requirements. There has been steady to rapid growth in the market for CNS disorder, especially over the past two decades. The market for CNS therapies is one of the…
CNS Therapeutics Market Research Report 2016
“Global CNS Therapeutics Market Research Report 2016” Order This Report by calling BigMarketResearch.com at +1-971-202-1575
Notes:
Production, means the output of CNS Therapeutics
Revenue, means the sales value of CNS Therapeutics
This report studies CNS Therapeutics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering
Pfizer, Inc. (USA)
Johnson & Johnson (USA)
Bristol-Myers Squibb…
